Clinically, high SMOC2 levels correlate with poor cancer prognosis13 as they promote epithelial-to-mesenchymal transformation and induce clonal metastatic tumor cell growth with a strong angiogenic activity9,10,14. The gene discussed is SMOC2; the disease is cancer.